Express Pharma

USFDA concludes inspection of Unichem Lab’s Ghaziabad facility


The inspection was successfully conducted from March 3-8, 2019, without any USFDA form 483 being issued

Drug firm Unichem Laboratories has said the US health regulator has concluded inspection of its Ghaziabad facility without making any observations. The US Food and Drug Administration (USFDA) conducted inspection of the company’s Ghaziabad facility from March 3-8, 2019, and it has been successfully concluded without any USFDA form 483 issued, Unichem Laboratories said recently. A form 483 is issued by the USFDA to notify a company’s management of any objectionable condition at its manufacturing facility. It is issued after completing the inspection.

Comments are closed.